Evonik partners with Coopmed for distribution of wound dressing epicite® in Germany
Coopmed will distribute the epicite® dressing made from biosynthetic cellulose exclusively to the German market for chronic wound care. ... MORE
EUDRACAP® ready-to-fill capsules now in IPEC-GMP quality
Evonik’s EUDRACAP® enteric easy-to-handle capsules are now globally available produced under IPEC-GMP. Launched last year, EUDRACAP® enteric are functional, ready-to-fill capsules that help pharmaceutical companies bring complex oral drug products to market faster. ... MORE
Non-animal-derived collagen platform Vecollan® now available at commercial scale
Evonik’s recombinant, non-animal-derived collagen platform is now available at commercial scale. Vecollan® is highly pure and soluble collagen that is produced via fermentation. ... MORE
New lipid production facility in the U.S.
The new plant at Evonik’s Tippecanoe site in Lafayette, Indiana, will broadly position the Group for future growth in novel mRNA-based therapies beyond COVID-19 vaccines and strengthen its leading role as a strategic partner for innovative pharmaceutical companies worldwide. ... MORE
EUDRATEC® SoluFlow - our new technology for drug solubility enhancement of oral small molecules
Learn more about the unique emulsion-based process and how it helps overcome the limitations of your poorly soluble API ... MORE
OUR SOLUTIONS- WE SPECIALIZE WHERE YOU NEED US MOST
EUDRAGIT® oral excipients
Unlock the Potential of Your API with our oral excipients ... MORE
AvailOm omega-3 powder supplement
The highest load omega-3 powder ingredient in its class for dietary supplements ... MORE
Biomaterials for medical implants
Biodegradable material solutions to enhance the safety, biocompatibility and performance of medical implants ... MORE
A Global CDMO Leader for LNPs
As a CDMO expert we provide modern, established sites for LNP manufacturing and filling, as well as process technologies for CGMP manufacturing ... MORE
Our CMO services
Evonik is a preferred CMO Partner for APIs, HPAPIs, intermediates and products made by fermentation ... MORE
Coatings for dietary supplements
Dietary supplements that leverage our advanced health ingredients and oral dosage form expertise ... MORE
Pharmaceutical Biomaterials
We are a Market Leader for Parenteral Excipients ... MORE
Oral Drug Delivery Systems
Our broad and flexible portfolio of drug delivery systems enables you to to optimize drug performance with superior targeting outcomes ... MORE
Your next CDMO for parenteral drug delivery
Evonik is one of the world’s leading CDMO for complex parenteral drug products ... MORE
ENDEXO® surface modification
Proprietary surface modification technology to improve medical device safety and functionality ... MORE
Ready-to-fill coated capsules for fast drug development
EUDRACAP® leverages the functional versatility and safety of EUDRAGIT® to solve key challenges in oral drug delivery ... MORE
Do you know our LinkedIn channel?
Follow Evonik Health Care on LinkedIn to keep updated about our products, webinars and news ... MORE
customer portal
Visit onCare to access all product and regulatory information, 24/7 ... MORE
Latest news
Health Care
Evonik launches non-animal-derived collagen platform Vecollan® at commercial scale for medical device applications
Evonik’s recombinant, non-animal-derived collagen platform is now available at commercial scale. Vecollan® is highly pure and soluble collagen that is produced via fermentation. ... MORE
Health Care
Evonik invests US$220 million in partnership with the U.S. Government to build new lipid production facility for mRNA-based therapies in the U.S.
The new plant will broadly position the Group for future growth in mRNA-based therapies and strengthen its leading role as a strategic partner for pharmaceutical companies worldwide. ... MORE
Health Care
Evonik realigns its Health Care business to maximize customer centricity
Evonik is transforming its Health Care business to maximize customer centricity and market focus. Effective April 1, 2022, the company will streamline its operations into three new product lines: Drug Delivery & Product, Drug Substance, and Health Solutions. ... MORE
Health Care
Evonik to increase prices for the Health Care portfolio
Effective April 1, 2022, Evonik’s Health Care business line will be implementing a price increase of up to 45 percent across the portfolio of products, technologies, and services for pharmaceutical, nutraceutical and medical device markets. ... MORE
Health Care
Evonik launches new EUDRATEC® technology to improve solubility of oral small molecules
EUDRATEC® SoluFlow, a new microparticle technology for solubility enhancement of APIs, overcomes solubility hurdles that cannot be resolved by existing manufacturing technologies. ... MORE
Health Care
Evonik increases global supply of pharma-grade plant-derived cholesterol for mRNA vaccines and gene therapies
Plant-derived cholesterol is one of the most critical components for the manufacture of mRNA vaccines and gene therapies. The large-scale production of PhytoChol® in Hanau, Germany, will meet an increased market demand for cholesterol. ... MORE
Health Care
Evonik recognized as a leading contract manufacturing organization for the pharma industry for the 5th consecutive year
Organized by the publications Life Science Leader and Outsourced Pharma, the CMO Leadership Awards highlight excellence in pharmaceutical contract manufacturing across six categories. ... MORE
Online seminars
Each year, we put up a program of online and in-person workshops, deep-diving into design, handling and processing of our products as well as latest challenges, solutions and trends in the industry. ... MORE
Health Care Newsletter
Subscribe to the Health Care Bulletin to stay up-to-date on industry trends, new Evonik products and services, scientific updates and upcoming events and webinars. ... MORE
Health Care
Evonik cooperates with Coopmed for distribution of wound dressing epicite®
... MORE